Analysts Have Made A Financial Statement On Shoulder Innovations, Inc.'s (NYSE:SI) First-Quarter Report
Shoulder Innovations SI | 0.00 |
It's been a pretty great week for Shoulder Innovations, Inc. (NYSE:SI) shareholders, with its shares surging 18% to US$15.63 in the week since its latest first-quarter results. Results were mixed, with revenues of US$17m beating expectations by 15%. Shoulder Innovations continued to be lossmaking, reporting a US$0.41 statutory loss per share, in line with analyst forecasts. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
Following the latest results, Shoulder Innovations' four analysts are now forecasting revenues of US$67.3m in 2026. This would be a major 25% improvement in revenue compared to the last 12 months. Losses are predicted to fall substantially, shrinking 20% to US$1.70. Before this earnings announcement, the analysts had been modelling revenues of US$64.1m and losses of US$1.57 per share in 2026. Overall it looks as though the analysts were a bit mixed on the latest consensus updates. Although there was a nice uplift to revenue, the consensus also made a modest increase to its losses per share forecasts.
There was no major change to the consensus price target of US$21.25, with growing revenues seemingly enough to offset the concern of growing losses. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Shoulder Innovations at US$24.00 per share, while the most bearish prices it at US$19.00. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's pretty clear that there is an expectation that Shoulder Innovations' revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 35% growth on an annualised basis. This is compared to a historical growth rate of 56% over the past year. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 8.0% annually. Even after the forecast slowdown in growth, it seems obvious that Shoulder Innovations is also expected to grow faster than the wider industry.
The Bottom Line
The most important thing to take away is that the analysts increased their loss per share estimates for next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Shoulder Innovations going out to 2028, and you can see them free on our platform here..
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
